Ophthalmology · Glaucoma

The Path to Lower Pressure: Medications, Lasers, and Surgery

At a Glance

Treatment for hypersecretion glaucoma focuses on lowering pressure inside the eye to protect vision. Depending on the cause and disease stage, care may include drops that reduce fluid production or improve drainage, laser procedures, surgery, or treatment of an underlying vascular or steroid-related cause.

The goal of treating high eye pressure is always to protect your vision by reaching a target IOP (intraocular pressure). Even if your eye is not naturally overproducing fluid—as the old “hypersecretion” label suggested—the most effective way to lower your pressure is often to artificially turn down the “faucet” or clear the “drain.” Treatment choices are highly individualized based on your disease stage, overall health, and the underlying cause ^[1]^[2].

Medications: Managing the Faucet and Drain

Doctors use several classes of eye drops to balance the fluid in your eye.

Turning Down the Faucet (Aqueous Suppressants)

These medications work by telling the ciliary body to slow down its production of fluid ^[3].

Beta-Blockers (e.g., Timolol): These drops block signals that stimulate fluid production. Important: Because they can enter the bloodstream, they can cause bronchospasms, slow heart rate (bradycardia), or dangerously low blood pressure. They must be used with caution in people with asthma, COPD, or heart rhythm issues ^[4]^[5].
Carbonic Anhydrase Inhibitors (CAIs) (e.g., Dorzolamide): These interfere with an enzyme the eye needs to create fluid. They are available as drops or as a pill (Acetazolamide) for more urgent pressure spikes. They have specific contraindications, including certain kidney issues and sulfa allergies ^[6]^[5].
Alpha-Agonists (e.g., Brimonidine): These slightly reduce fluid production while also helping fluid leave through the “back door” pathway ^[7].

Opening the Drain (Outflow Enhancers)

These drops help the eye’s natural drainage systems work more efficiently.

Prostaglandin Analogs (e.g., Latanoprost): Often a first-line treatment, these primarily increase outflow through the uveoscleral (“back door”) pathway ^[8]^[9].
ROCK Inhibitors (e.g., Netarsudil): These target the main trabecular meshwork to reduce resistance. They frequently cause marked conjunctival redness as a side effect ^[10].

💧 Proper Eye Drop Technique

Wash your hands and avoid letting the bottle tip touch your eye.

After instilling the drop, close your eye and gently press the inner corner by your nose for about one minute (punctal occlusion). This keeps the medicine in your eye and prevents it from entering your bloodstream.

If you use multiple drops, wait 5 minutes between each. Ask your doctor what to do if you miss a dose, and never stop a medication without consulting them.

Laser and Surgical Options

When drops aren’t enough, procedures can help manage the pressure.

Selective Laser Trabeculoplasty (SLT): A doctor uses a laser to stimulate the eye’s drain. It is appropriate for selected angles, but its effect varies, can be temporary, and sometimes causes a short-term pressure spike ^[2]^[11].
MIGS (Minimally Invasive Glaucoma Surgery): Often performed alongside cataract surgery, these tiny stents improve drainage. While generally safer than major surgeries, they carry real risks and usually provide more modest pressure lowering ^[12]^[13].
Filtration Surgery (Trabeculectomy or Drainage Devices): For advanced disease, surgeons may create a new drain. A glaucoma drainage device (which may or may not be valved) is a tube connected to a small plate that carries fluid out of the eye ^[14]^[15].
Cyclophotocoagulation (CPC): This uses laser energy to treat the ciliary body directly, reducing fluid production at the source. It carries significant risks, including inflammation, vision loss, or the eye becoming too soft (hypotony), and timing is highly individualized ^[16]^[17].

Treating the Root Cause

⚠️ WARNING ON STEROIDS
If your high pressure is steroid-induced, never abruptly stop a prescribed systemic, inhaled, or topical steroid on your own. The underlying disease you are treating may require it, and sudden withdrawal can be dangerous. Any tapering or substitution must be coordinated directly between your prescribing clinician and your ophthalmologist. Keep in mind that eye pressure may persist and require glaucoma treatment even after the steroid is changed ^[18].

If the high pressure is caused by a blood vessel problem like a carotid-cavernous fistula, endovascular treatment (like an embolization by a specialist) is often central to care. However, fixing the fistula does not guarantee eye pressure will immediately or completely normalize; ongoing ophthalmic care is usually required ^[19]^[20].

Common questions in this guide

How is hypersecretion glaucoma or high eye pressure usually treated?

There is no single best treatment for everyone. Eye drops may reduce fluid production or help fluid drain, and prostaglandin analogs are often used first; laser treatment or surgery may be considered when drops are not enough. The choice depends on your disease stage, overall health, eye anatomy, and the cause of the pressure.

Can beta-blocker eye drops be used if I have asthma or heart problems?

Beta-blocker drops can enter the bloodstream and may worsen breathing problems, slow the heart rate, or lower blood pressure. Tell your ophthalmologist about asthma, COPD, a slow heart rate, or heart rhythm problems before using them. Pressing gently at the inner corner of the eye after applying a drop can reduce absorption but does not replace medical advice.

Can selective laser trabeculoplasty reduce my need for glaucoma drops?

Selective laser trabeculoplasty can improve drainage in people with suitable eye angles and may reduce the need for drops. Its effect varies, may wear off, and can briefly raise eye pressure. Your ophthalmologist can determine whether your eye anatomy and pressure pattern make it appropriate.

What surgery may be used when glaucoma drops are not enough?

Minimally invasive glaucoma surgery, often done with cataract surgery, can improve drainage with less recovery burden than major surgery but usually lowers pressure more modestly. Trabeculectomy and glaucoma drainage devices create or use a stronger drainage pathway and may be considered for advanced or difficult-to-control disease. Cyclophotocoagulation reduces fluid production but has important risks, so its timing is individualized.

Should I stop a steroid if it may be raising my eye pressure?

Do not stop a prescribed systemic, inhaled, or topical steroid abruptly on your own. The condition being treated may require the steroid, and sudden withdrawal can be dangerous. The prescribing clinician and ophthalmologist should coordinate any taper or substitution, and glaucoma treatment may still be needed after the steroid changes.

Will treating a carotid-cavernous fistula make my eye pressure normal?

Endovascular treatment, such as embolization, may be central when a carotid-cavernous fistula is causing high eye pressure. However, treating the fistula does not guarantee that pressure will normalize immediately or completely. Continued monitoring and treatment by an ophthalmologist are often needed.

How can I use glaucoma eye drops more safely and effectively?

Wash your hands, avoid touching the bottle tip to your eye, and close your eye after the drop while gently pressing the inner corner near your nose for about one minute. Wait about five minutes between different drops. Ask your clinician what to do after a missed dose, and do not stop treatment without guidance.

Curated prompts to bring to your next appointment.

1.Based on my exam, should we start with a drug that 'turns down the faucet' or one that 'opens the drain'?
2.If we suspect my high pressure is actually a vascular backup, would an endovascular procedure be better for me than eye surgery?
3.Am I a candidate for Selective Laser Trabeculoplasty (SLT) to help improve my natural drainage?
4.Given my health history, are there any risks to my heart or lungs if we use beta-blocker eye drops?
5.If my pressure remains high, is a drainage device or a 'tube shunt' a safer option for me than a trabeculectomy?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Key takeaways

Treatment aims to reach a target eye pressure that protects vision, with choices based on disease stage, overall health, and the underlying cause.
Eye drops lower fluid production or improve drainage; prostaglandin analogs are often first-line, but medication risks and contraindications matter.
Pressing the inner corner of the eye after applying a drop and spacing different drops can improve technique and limit bloodstream exposure.
Selective laser trabeculoplasty, minimally invasive surgery, filtration surgery, drainage devices, and cyclophotocoagulation are options when drops are insufficient.
Steroid-related pressure requires coordinated medication changes rather than abrupt steroid withdrawal, and treating a carotid-cavernous fistula may not immediately normalize eye pressure.

References (20)

1
[Primary open-angle glaucoma].
Bertaud S, Aragno V, Baudouin C, Labbé A
La Revue de medecine interne 2019; (40(7)):445-452 doi:10.1016/j.revmed.2018.12.001.
PMID: 30594326
2
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
Gazzard G, Konstantakopoulou E, Garway-Heath D, et al.
Lancet (London, England) 2019; (393(10180)):1505-1516 doi:10.1016/S0140-6736(18)32213-X.
PMID: 30862377
3
Controversies in Glaucoma: Current Medical Treatment and Drug Development.
Bucolo C, Platania CB, Reibaldi M, et al.
Current pharmaceutical design 2015; (21(32)):4673-81 doi:10.2174/1381612821666150909095553.
PMID: 26350532
4
Ophthalmic Timolol and Hospitalization for Symptomatic Bradycardia and Syncope: A Case Series.
Abbas SA, Hamadani SM, Ahmad U, et al.
Cureus 2020; (12(3)):e7270 doi:10.7759/cureus.7270.
PMID: 32292680
5
FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma.
Sharif NA, Odani-Kawabata N, Lu F, Pinchuk L
Experimental eye research 2023; (229()):109415 doi:10.1016/j.exer.2023.109415.
PMID: 36803996
6
Evaluation of the Efficacy Duration of Topical Therapies in Eyes with Primary Open-Angle Glaucoma.
Lanza M, Leone A, Scognamiglio G, et al.
Journal of clinical medicine 2022; (11(20)) doi:10.3390/jcm11206166.
PMID: 36294484
7
Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis.
Li F, Huang W, Zhang X
Acta ophthalmologica 2018; (96(3)):e277-e284 doi:10.1111/aos.13568.
PMID: 29144028
8
How latanoprost changed glaucoma management.
Cordeiro MF, Gandolfi S, Gugleta K, et al.
Acta ophthalmologica 2024; (102(2)):e140-e155 doi:10.1111/aos.15725.
PMID: 37350260
9
A Randomised Open Label Comparative Clinical Trial on the Efficacy of Latanoprost and Timolol in Primary Open Angle Glaucoma.
Rao S, Narayanan PV
Journal of clinical and diagnostic research : JCDR 2016; (10(1)):FC13-5 doi:10.7860/JCDR/2016/16923.7135.
PMID: 26894085
10
Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision.
Sharif NA
Neural regeneration research 2018; (13(7)):1145-1150 doi:10.4103/1673-5374.235017.
PMID: 30028313
11
[Selective laser trabeculoplasty: Effect of number of preoperative topical glaucoma medications on pressure lowering and success rate].
Bonnel S, Fenolland JR, Marill AF, et al.
Journal francais d'ophtalmologie 2017; (40(1)):22-28 doi:10.1016/j.jfo.2016.11.003.
PMID: 28081918
12
The effect of cataract surgery on lowering intraocular pressure.
Shah YS, Garg AK, Ramulu PY
Current opinion in ophthalmology 2025; (36(1)):46-53 doi:10.1097/ICU.0000000000001112.
PMID: 39601279
13
Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis.
Lavia C, Dallorto L, Maule M, et al.
PloS one 2017; (12(8)):e0183142 doi:10.1371/journal.pone.0183142.
PMID: 28850575
14
Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: a prospective randomized clinical trial.
Matlach J, Dhillon C, Hain J, et al.
Acta ophthalmologica 2015; (93(8)):753-61 doi:10.1111/aos.12722.
PMID: 25847610
15
Ahmed valve implantation in childhood glaucoma associated with Sturge-Weber syndrome: our experience.
Kaushik J, Parihar JKS, Jain VK, Mathur V
Eye (London, England) 2019; (33(3)):464-468 doi:10.1038/s41433-018-0233-x.
PMID: 30337636
16
[Cyclophotocoagulation - current applications and practical aspects].
van Oterendorp C, Drüke D
Klinische Monatsblatter fur Augenheilkunde 2023; (240(6)):835-848 doi:10.1055/a-1984-3660.
PMID: 37236237
17
An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma.
Souissi S, Le Mer Y, Metge F, et al.
Acta ophthalmologica 2021; (99(5)):e621-e653 doi:10.1111/aos.14661.
PMID: 33222409
18
[Glaucoma due to elevated episcleral venous pressure].
Greslechner R, Oberacher-Velten I
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2019; (116(5)):423-429 doi:10.1007/s00347-018-0828-4.
PMID: 30506098
19
Onyx Embolization of Carotid-Cavernous Fistulas and Its Impact on Intraocular Pressure and Recurrence: A Case Series.
Al Saiegh F, Baldassari MP, Sweid A, et al.
Operative neurosurgery (Hagerstown, Md.) 2021; (20(2)):174-182 doi:10.1093/ons/opaa308.
PMID: 33027818
20
Intraocular Pressure in the Eyes of Patients With Carotid-Cavernous Fistulas: Profile, Intereye Asymmetry, and Treatment Outcomes.
Khurana M, Alam MS, Balekudaru S, et al.
Journal of glaucoma 2019; (28(12)):1074-1078 doi:10.1097/IJG.0000000000001392.
PMID: 31658226

This page is for informational purposes only and does not constitute medical advice. An ophthalmologist should tailor treatment to your pressure, disease stage, underlying cause, and other health conditions.

Get notified when new evidence is published on hypersecretion glaucoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents